Bu2Sn(N-acetyl-L-cysteinate) antitumor activity on HepG2 cells
- Autori: Pellerito, C.; Prinzivalli, C.; Casella, G.; Fiore, T.; Pellerito, O.; Giuliano, M.; Scopelliti, M.; Pellerito, L.
- Anno di pubblicazione: 2010
- Tipologia: Contributo in atti di convegno pubblicato in volume
- Parole Chiave: antitumor activity; HepG2 cells; organotin(IV)
- OA Link: http://hdl.handle.net/10447/65946
Abstract
Many drugs currently used in anticancer therapies, act by activating cytotoxic death by apoptosis. This death mechanism is often accompanied by mitochondrial events (intrinsic apoptosis) or the activation of death receptors (extrinsic pathway)